[SGMO] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
05-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 16.27%
YoY- -18.64%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 6,835 29,378 27,872 21,553 17,548 21,416 8,253 -3.09%
PBT -120,770 -43,091 -47,150 -35,965 -30,356 -16,640 -12,491 45.93%
Tax -6,264 82 24 -36 -72 0 0 -
NP -114,506 -43,173 -47,169 -35,929 -30,284 -16,640 -12,491 44.64%
Tax Rate - - - - - - - -
Total Cost 121,341 72,551 75,041 57,482 47,832 38,056 20,744 34.21%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -1,675.29 -146.96 -169.23 -166.70 -172.58 -77.70 -151.35 49.25%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.66 -0.29 -0.33 -0.26 -0.26 -0.17 -0.17 25.35%
EPS Diluted -0.66 -0.29 -0.33 -0.26 -0.26 -0.17 -0.17 25.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.